Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.67050478 |
2 | cardiac myofibril assembly (GO:0055003) | 5.49499192 |
3 | sarcomere organization (GO:0045214) | 5.47761251 |
4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.40425695 |
5 | plasma membrane repair (GO:0001778) | 5.27540107 |
6 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.25897443 |
7 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.21922702 |
8 | muscle filament sliding (GO:0030049) | 5.16191735 |
9 | actin-myosin filament sliding (GO:0033275) | 5.16191735 |
10 | myofibril assembly (GO:0030239) | 5.13145419 |
11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.90298661 |
12 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.83828509 |
13 | regulation of skeletal muscle contraction (GO:0014819) | 4.81944423 |
14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.78891332 |
15 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.66282433 |
16 | cellular response to epinephrine stimulus (GO:0071872) | 4.60129004 |
17 | cardiac muscle contraction (GO:0060048) | 4.55944750 |
18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.49088914 |
19 | regulation of cell communication by electrical coupling (GO:0010649) | 4.43400778 |
20 | actin-mediated cell contraction (GO:0070252) | 4.34360545 |
21 | response to epinephrine (GO:0071871) | 4.32739696 |
22 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.31488089 |
23 | regulation of relaxation of muscle (GO:1901077) | 4.20785327 |
24 | regulation of membrane repolarization (GO:0060306) | 4.10242578 |
25 | striated muscle contraction (GO:0006941) | 4.07039025 |
26 | cell communication by electrical coupling (GO:0010644) | 4.05984618 |
27 | regulation of actin filament-based movement (GO:1903115) | 4.02827726 |
28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.99146872 |
29 | cell communication involved in cardiac conduction (GO:0086065) | 3.98374658 |
30 | actomyosin structure organization (GO:0031032) | 3.97352485 |
31 | cardiac muscle hypertrophy (GO:0003300) | 3.84606581 |
32 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.82578814 |
33 | cardiac muscle cell development (GO:0055013) | 3.82061854 |
34 | cardiac chamber formation (GO:0003207) | 3.81669066 |
35 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.80234997 |
36 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.73232737 |
37 | striated muscle hypertrophy (GO:0014897) | 3.73052179 |
38 | detection of calcium ion (GO:0005513) | 3.64153860 |
39 | cardiac cell development (GO:0055006) | 3.61020563 |
40 | response to caffeine (GO:0031000) | 3.57399262 |
41 | regulation of striated muscle contraction (GO:0006942) | 3.57259675 |
42 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.53501713 |
43 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.53501713 |
44 | carnitine shuttle (GO:0006853) | 3.53122134 |
45 | regulation of ATPase activity (GO:0043462) | 3.52528581 |
46 | regulation of ATP catabolic process (GO:1903289) | 3.52528581 |
47 | actin filament-based movement (GO:0030048) | 3.49540523 |
48 | cardiac ventricle formation (GO:0003211) | 3.48905707 |
49 | adrenergic receptor signaling pathway (GO:0071875) | 3.47100046 |
50 | regulation of sarcomere organization (GO:0060297) | 3.44967858 |
51 | regulation of synapse structural plasticity (GO:0051823) | 3.44607381 |
52 | adult heart development (GO:0007512) | 3.41725765 |
53 | relaxation of cardiac muscle (GO:0055119) | 3.38010701 |
54 | skeletal muscle contraction (GO:0003009) | 3.35320760 |
55 | cardiac conduction (GO:0061337) | 3.29233546 |
56 | regulation of cardioblast differentiation (GO:0051890) | 3.28848486 |
57 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.27413293 |
58 | positive regulation of heart rate (GO:0010460) | 3.27022837 |
59 | muscle hypertrophy (GO:0014896) | 3.25188205 |
60 | * regulation of muscle contraction (GO:0006937) | 3.24835997 |
61 | striated muscle cell development (GO:0055002) | 3.22469700 |
62 | * regulation of muscle system process (GO:0090257) | 3.21538230 |
63 | cardiac muscle cell action potential (GO:0086001) | 3.19686487 |
64 | muscle fiber development (GO:0048747) | 3.19513955 |
65 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.18356873 |
66 | tricarboxylic acid cycle (GO:0006099) | 3.17737172 |
67 | positive regulation of cation channel activity (GO:2001259) | 3.16899135 |
68 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.13624382 |
69 | heart contraction (GO:0060047) | 3.13322480 |
70 | heart process (GO:0003015) | 3.13322480 |
71 | negative regulation of protein localization to cell surface (GO:2000009) | 3.12222855 |
72 | negative regulation of myotube differentiation (GO:0010832) | 3.11306147 |
73 | regulation of the force of heart contraction (GO:0002026) | 3.11124916 |
74 | muscle contraction (GO:0006936) | 3.09422846 |
75 | regulation of cardiac muscle contraction (GO:0055117) | 3.09277471 |
76 | negative regulation of potassium ion transport (GO:0043267) | 3.07592640 |
77 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.07496064 |
78 | potassium ion import (GO:0010107) | 3.06560615 |
79 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.06553291 |
80 | creatine metabolic process (GO:0006600) | 3.05872560 |
81 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.04143885 |
82 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.03344322 |
83 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.02565120 |
84 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.02499258 |
85 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.01691614 |
86 | cardiac muscle adaptation (GO:0014887) | 3.00382656 |
87 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.00382656 |
88 | muscle hypertrophy in response to stress (GO:0003299) | 3.00382656 |
89 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.99133350 |
90 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.98825159 |
91 | positive regulation of sodium ion transport (GO:0010765) | 2.98788960 |
92 | fatty acid transmembrane transport (GO:1902001) | 2.93786304 |
93 | cardiac muscle tissue development (GO:0048738) | 2.93131417 |
94 | carnitine transmembrane transport (GO:1902603) | 2.90883492 |
95 | membrane depolarization during action potential (GO:0086010) | 2.90878418 |
96 | muscle system process (GO:0003012) | 2.89773691 |
97 | vocalization behavior (GO:0071625) | 2.89687046 |
98 | muscle tissue morphogenesis (GO:0060415) | 2.89459375 |
99 | locomotory exploration behavior (GO:0035641) | 2.89445982 |
100 | regulation of cation channel activity (GO:2001257) | 2.88468476 |
101 | heart trabecula formation (GO:0060347) | 2.88391805 |
102 | regulation of heart rate (GO:0002027) | 2.86775867 |
103 | cellular response to catecholamine stimulus (GO:0071870) | 2.86751255 |
104 | cellular response to monoamine stimulus (GO:0071868) | 2.86751255 |
105 | activation of protein kinase A activity (GO:0034199) | 2.83663632 |
106 | regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 2.82792486 |
107 | positive regulation of heart contraction (GO:0045823) | 2.82142546 |
108 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.81072489 |
109 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.78920452 |
110 | regulation of heart contraction (GO:0008016) | 2.78686518 |
111 | relaxation of muscle (GO:0090075) | 2.78626164 |
112 | synaptic vesicle maturation (GO:0016188) | 2.77833753 |
113 | response to inactivity (GO:0014854) | 2.76641659 |
114 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.74781595 |
115 | striated muscle adaptation (GO:0014888) | 2.74243297 |
116 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.72093631 |
117 | sodium ion export (GO:0071436) | 2.68203670 |
118 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.67111755 |
119 | skeletal muscle adaptation (GO:0043501) | 2.66831674 |
120 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.66536131 |
121 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.66532257 |
122 | regulation of cofactor metabolic process (GO:0051193) | 2.65115116 |
123 | regulation of coenzyme metabolic process (GO:0051196) | 2.65115116 |
124 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.64822338 |
125 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.61086546 |
126 | positive regulation of potassium ion transport (GO:0043268) | 2.59033051 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.58173369 |
2 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54258252 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.44640417 |
4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.41808339 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36273490 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34430518 |
7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23464269 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23464269 |
9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.15193578 |
10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06012177 |
11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05982307 |
12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97976591 |
13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94070338 |
14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.93589614 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.92417862 |
16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.90308736 |
17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85939917 |
18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84204681 |
19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.79221819 |
20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78675294 |
21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74197382 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72371209 |
23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68599248 |
24 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.60304642 |
25 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.60304642 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60196087 |
27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53362650 |
28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52593145 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50828264 |
30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48418195 |
31 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47204194 |
32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45208684 |
33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42125049 |
34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.40196168 |
35 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.36972154 |
36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33463052 |
37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30300138 |
38 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30051806 |
39 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28272345 |
40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28207001 |
41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28201653 |
42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26914039 |
43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26572176 |
44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25928051 |
45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25611984 |
46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25200347 |
47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19917114 |
48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19805597 |
49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18856230 |
50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17774567 |
51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17677267 |
52 | AR_19668381_ChIP-Seq_PC3_Human | 1.17648892 |
53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17479537 |
54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17367222 |
55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16845207 |
56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16219767 |
57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15810604 |
58 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.14927044 |
59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14436882 |
60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13103851 |
61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12954484 |
62 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12583154 |
63 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12322547 |
64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10742526 |
65 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10452060 |
66 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10452060 |
67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10368913 |
68 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08769355 |
69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08662908 |
70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08392052 |
71 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07640749 |
72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07279463 |
73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06968982 |
74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05792151 |
75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05210744 |
76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04581252 |
77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04371969 |
78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04111717 |
79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02783732 |
80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.02596908 |
81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02462735 |
82 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02369559 |
83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01252577 |
84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00765507 |
85 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.99626103 |
86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99606678 |
87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99130661 |
88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98613976 |
89 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98561065 |
90 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98415063 |
91 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97568172 |
92 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97559812 |
93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97219058 |
94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96453415 |
95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96420245 |
96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96272247 |
97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96094825 |
98 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94185090 |
99 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94129029 |
100 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93808692 |
101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93342415 |
102 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93116550 |
103 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93022207 |
104 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92905088 |
105 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92435438 |
106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92429109 |
107 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92285283 |
108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92046958 |
109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91703276 |
110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91703276 |
111 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91651095 |
112 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91638176 |
113 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90791005 |
114 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.90705490 |
115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90287121 |
116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89823248 |
117 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89772846 |
118 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88931767 |
119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88549431 |
120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88273632 |
121 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87654044 |
122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87571173 |
123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87424636 |
124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86714637 |
125 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86662198 |
126 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86471054 |
127 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86235963 |
128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86024475 |
129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85598051 |
130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84980098 |
131 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84936651 |
132 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84671074 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 5.33767313 |
2 | MP0000751_myopathy | 5.09965881 |
3 | MP0003646_muscle_fatigue | 4.55276112 |
4 | MP0004084_abnormal_cardiac_muscle | 4.02470941 |
5 | MP0004215_abnormal_myocardial_fiber | 3.78850026 |
6 | MP0004036_abnormal_muscle_relaxation | 3.59523051 |
7 | MP0000749_muscle_degeneration | 3.51070123 |
8 | MP0004145_abnormal_muscle_electrophysio | 3.24837165 |
9 | MP0004859_abnormal_synaptic_plasticity | 3.16626215 |
10 | MP0005330_cardiomyopathy | 2.90718293 |
11 | MP0004130_abnormal_muscle_cell | 2.69947557 |
12 | MP0004087_abnormal_muscle_fiber | 2.69736223 |
13 | MP0005620_abnormal_muscle_contractility | 2.66413133 |
14 | MP0002972_abnormal_cardiac_muscle | 2.42092443 |
15 | MP0003137_abnormal_impulse_conducting | 2.39053399 |
16 | MP0002106_abnormal_muscle_physiology | 2.37198383 |
17 | MP0004484_altered_response_of | 2.23122708 |
18 | MP0008775_abnormal_heart_ventricle | 2.16846003 |
19 | MP0000750_abnormal_muscle_regeneration | 2.15646742 |
20 | MP0000747_muscle_weakness | 2.12619097 |
21 | MP0002269_muscular_atrophy | 2.05164882 |
22 | MP0005369_muscle_phenotype | 1.99742130 |
23 | MP0000759_abnormal_skeletal_muscle | 1.99037957 |
24 | MP0004085_abnormal_heartbeat | 1.92658038 |
25 | MP0004510_myositis | 1.86972495 |
26 | MP0010630_abnormal_cardiac_muscle | 1.83264848 |
27 | MP0001544_abnormal_cardiovascular_syste | 1.82640046 |
28 | MP0005385_cardiovascular_system_phenoty | 1.82640046 |
29 | MP0004233_abnormal_muscle_weight | 1.82288104 |
30 | MP0009780_abnormal_chondrocyte_physiolo | 1.79364004 |
31 | MP0003635_abnormal_synaptic_transmissio | 1.75822252 |
32 | MP0004270_analgesia | 1.72094229 |
33 | MP0006138_congestive_heart_failure | 1.69591289 |
34 | MP0000013_abnormal_adipose_tissue | 1.44951381 |
35 | MP0009745_abnormal_behavioral_response | 1.34015534 |
36 | MP0003828_pulmonary_edema | 1.33190917 |
37 | MP0002063_abnormal_learning/memory/cond | 1.31560594 |
38 | MP0002822_catalepsy | 1.29543250 |
39 | MP0002909_abnormal_adrenal_gland | 1.28110518 |
40 | MP0009046_muscle_twitch | 1.27009390 |
41 | MP0003880_abnormal_central_pattern | 1.25374490 |
42 | MP0008961_abnormal_basal_metabolism | 1.25262607 |
43 | MP0001661_extended_life_span | 1.20157268 |
44 | MP0005666_abnormal_adipose_tissue | 1.18735629 |
45 | MP0002108_abnormal_muscle_morphology | 1.18585190 |
46 | MP0002127_abnormal_cardiovascular_syste | 1.18486034 |
47 | MP0008569_lethality_at_weaning | 1.15419965 |
48 | MP0002064_seizures | 1.14718663 |
49 | MP0002332_abnormal_exercise_endurance | 1.13772055 |
50 | MP0003045_fibrosis | 1.12240443 |
51 | MP0005670_abnormal_white_adipose | 1.06544007 |
52 | MP0004858_abnormal_nervous_system | 1.04783403 |
53 | MP0002234_abnormal_pharynx_morphology | 1.03878461 |
54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03616580 |
55 | MP0005623_abnormal_meninges_morphology | 1.01836741 |
56 | MP0001486_abnormal_startle_reflex | 1.00753511 |
57 | MP0005375_adipose_tissue_phenotype | 1.00723243 |
58 | MP0000462_abnormal_digestive_system | 0.99561602 |
59 | MP0002572_abnormal_emotion/affect_behav | 0.98070041 |
60 | MP0003950_abnormal_plasma_membrane | 0.97458022 |
61 | MP0002735_abnormal_chemical_nociception | 0.96706003 |
62 | MP0002734_abnormal_mechanical_nocicepti | 0.96280754 |
63 | MP0004185_abnormal_adipocyte_glucose | 0.95273304 |
64 | MP0002272_abnormal_nervous_system | 0.94249187 |
65 | MP0001968_abnormal_touch/_nociception | 0.93921591 |
66 | MP0004924_abnormal_behavior | 0.93536896 |
67 | MP0005386_behavior/neurological_phenoty | 0.93536896 |
68 | MP0008004_abnormal_stomach_pH | 0.93387283 |
69 | MP0001440_abnormal_grooming_behavior | 0.90783935 |
70 | MP0000003_abnormal_adipose_tissue | 0.90383484 |
71 | MP0005451_abnormal_body_composition | 0.89802044 |
72 | MP0005503_abnormal_tendon_morphology | 0.86535798 |
73 | MP0003279_aneurysm | 0.86487010 |
74 | MP0000230_abnormal_systemic_arterial | 0.83009073 |
75 | MP0000767_abnormal_smooth_muscle | 0.83004731 |
76 | MP0002128_abnormal_blood_circulation | 0.80416826 |
77 | MP0002067_abnormal_sensory_capabilities | 0.79339820 |
78 | MP0000266_abnormal_heart_morphology | 0.79304858 |
79 | MP0000733_abnormal_muscle_development | 0.76091509 |
80 | MP0001501_abnormal_sleep_pattern | 0.72463359 |
81 | MP0005423_abnormal_somatic_nervous | 0.72163613 |
82 | MP0005165_increased_susceptibility_to | 0.69321672 |
83 | MP0001299_abnormal_eye_distance/ | 0.68867603 |
84 | MP0002168_other_aberrant_phenotype | 0.68338097 |
85 | MP0005187_abnormal_penis_morphology | 0.66031269 |
86 | MP0004811_abnormal_neuron_physiology | 0.65905997 |
87 | MP0001970_abnormal_pain_threshold | 0.65258478 |
88 | MP0000569_abnormal_digit_pigmentation | 0.64718772 |
89 | MP0002184_abnormal_innervation | 0.64672152 |
90 | MP0003633_abnormal_nervous_system | 0.63090160 |
91 | MP0005266_abnormal_metabolism | 0.61984948 |
92 | MP0008438_abnormal_cutaneous_collagen | 0.60926770 |
93 | MP0002736_abnormal_nociception_after | 0.60557300 |
94 | MP0010386_abnormal_urinary_bladder | 0.60378149 |
95 | MP0005275_abnormal_skin_tensile | 0.60338187 |
96 | MP0001958_emphysema | 0.60045268 |
97 | MP0005409_darkened_coat_color | 0.59788520 |
98 | MP0001879_abnormal_lymphatic_vessel | 0.59436868 |
99 | MP0000343_altered_response_to | 0.59386339 |
100 | MP0001984_abnormal_olfaction | 0.59202297 |
101 | MP0005535_abnormal_body_temperature | 0.58992904 |
102 | MP0002066_abnormal_motor_capabilities/c | 0.58453399 |
103 | MP0002557_abnormal_social/conspecific_i | 0.58045448 |
104 | MP0000778_abnormal_nervous_system | 0.56620083 |
105 | MP0006036_abnormal_mitochondrial_physio | 0.56254634 |
106 | MP0003329_amyloid_beta_deposits | 0.55991445 |
107 | MP0009384_cardiac_valve_regurgitation | 0.55442239 |
108 | MP0002971_abnormal_brown_adipose | 0.55144079 |
109 | MP0004043_abnormal_pH_regulation | 0.55141274 |
110 | MP0004147_increased_porphyrin_level | 0.53684853 |
111 | MP0005167_abnormal_blood-brain_barrier | 0.53471452 |
112 | MP0010368_abnormal_lymphatic_system | 0.52538242 |
113 | MP0003566_abnormal_cell_adhesion | 0.51893322 |
114 | MP0004272_abnormal_basement_membrane | 0.51419518 |
115 | MP0002009_preneoplasia | 0.51008452 |
116 | MP0003879_abnormal_hair_cell | 0.50846600 |
117 | MP0005595_abnormal_vascular_smooth | 0.46904181 |
118 | MP0001664_abnormal_digestion | 0.46864281 |
119 | MP0002925_abnormal_cardiovascular_devel | 0.44520045 |
120 | MP0009115_abnormal_fat_cell | 0.43208524 |
121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.42851762 |
122 | MP0001784_abnormal_fluid_regulation | 0.39969173 |
123 | MP0002638_abnormal_pupillary_reflex | 0.39614098 |
124 | MP0003705_abnormal_hypodermis_morpholog | 0.37056761 |
125 | MP0001614_abnormal_blood_vessel | 0.36564835 |
126 | MP0002133_abnormal_respiratory_system | 0.34757224 |
127 | MP0005388_respiratory_system_phenotype | 0.34757224 |
128 | MP0003948_abnormal_gas_homeostasis | 0.31228254 |
129 | MP0003690_abnormal_glial_cell | 0.29946615 |
130 | MP0008874_decreased_physiological_sensi | 0.29586849 |
131 | MP0003091_abnormal_cell_migration | 0.28460167 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 6.78895071 |
2 | Exercise-induced myalgia (HP:0003738) | 6.11113832 |
3 | Calf muscle hypertrophy (HP:0008981) | 5.71946084 |
4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.48860353 |
5 | Exercise-induced muscle cramps (HP:0003710) | 5.14389996 |
6 | Muscle fiber splitting (HP:0003555) | 5.06477365 |
7 | Hyporeflexia of lower limbs (HP:0002600) | 4.90543366 |
8 | Abnormality of the calf musculature (HP:0001430) | 4.90087714 |
9 | Atrial fibrillation (HP:0005110) | 4.74277175 |
10 | Ventricular tachycardia (HP:0004756) | 4.71605175 |
11 | Type 1 muscle fiber predominance (HP:0003803) | 4.67940322 |
12 | Primary atrial arrhythmia (HP:0001692) | 4.47731423 |
13 | Muscle fiber inclusion bodies (HP:0100299) | 4.46641959 |
14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.30727587 |
15 | Supraventricular tachycardia (HP:0004755) | 4.25330179 |
16 | Bundle branch block (HP:0011710) | 4.23846574 |
17 | Supraventricular arrhythmia (HP:0005115) | 4.18244762 |
18 | Subaortic stenosis (HP:0001682) | 4.11621695 |
19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.11621695 |
20 | Syncope (HP:0001279) | 4.08444340 |
21 | Prolonged QT interval (HP:0001657) | 4.07888928 |
22 | Difficulty running (HP:0009046) | 4.05248087 |
23 | EMG: myopathic abnormalities (HP:0003458) | 4.00251750 |
24 | Increased connective tissue (HP:0009025) | 3.76291727 |
25 | Nemaline bodies (HP:0003798) | 3.74105116 |
26 | Myoglobinuria (HP:0002913) | 3.73239668 |
27 | Right ventricular cardiomyopathy (HP:0011663) | 3.71806210 |
28 | Lipoatrophy (HP:0100578) | 3.68906510 |
29 | Myotonia (HP:0002486) | 3.61486951 |
30 | Ventricular fibrillation (HP:0001663) | 3.45226233 |
31 | Ventricular arrhythmia (HP:0004308) | 3.40334049 |
32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.29835814 |
33 | Asymmetric septal hypertrophy (HP:0001670) | 3.21733213 |
34 | Heart block (HP:0012722) | 3.19065485 |
35 | Abnormal EKG (HP:0003115) | 3.10685424 |
36 | Dilated cardiomyopathy (HP:0001644) | 3.10091369 |
37 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.08953634 |
38 | Abnormal atrioventricular conduction (HP:0005150) | 2.99330159 |
39 | Difficulty climbing stairs (HP:0003551) | 2.82230458 |
40 | Atrioventricular block (HP:0001678) | 2.77840489 |
41 | Distal arthrogryposis (HP:0005684) | 2.77374322 |
42 | Palpitations (HP:0001962) | 2.73430841 |
43 | Facial diplegia (HP:0001349) | 2.70712055 |
44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.62915772 |
45 | Neck muscle weakness (HP:0000467) | 2.62802260 |
46 | Round ear (HP:0100830) | 2.62011547 |
47 | Focal motor seizures (HP:0011153) | 2.60996465 |
48 | Muscle stiffness (HP:0003552) | 2.57321618 |
49 | Myopathic facies (HP:0002058) | 2.51189989 |
50 | Hypoplastic ischia (HP:0003175) | 2.51100309 |
51 | Lower limb amyotrophy (HP:0007210) | 2.49123899 |
52 | Scapular winging (HP:0003691) | 2.42994532 |
53 | Distal lower limb amyotrophy (HP:0008944) | 2.42637739 |
54 | Left ventricular hypertrophy (HP:0001712) | 2.40279598 |
55 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.34830361 |
56 | Neoplasm of the heart (HP:0100544) | 2.34819101 |
57 | Rhabdomyolysis (HP:0003201) | 2.34310475 |
58 | Dysmetric saccades (HP:0000641) | 2.33345369 |
59 | Broad metatarsal (HP:0001783) | 2.30118748 |
60 | Aortic dissection (HP:0002647) | 2.27666557 |
61 | Rimmed vacuoles (HP:0003805) | 2.27475125 |
62 | Steppage gait (HP:0003376) | 2.26316212 |
63 | Aneurysm (HP:0002617) | 2.26244654 |
64 | EMG: neuropathic changes (HP:0003445) | 2.23952059 |
65 | Frequent falls (HP:0002359) | 2.22539101 |
66 | Limb-girdle muscle atrophy (HP:0003797) | 2.21449649 |
67 | Distal lower limb muscle weakness (HP:0009053) | 2.20878076 |
68 | Proximal amyotrophy (HP:0007126) | 2.20158490 |
69 | Abnormality of the ischium (HP:0003174) | 2.17747273 |
70 | Gowers sign (HP:0003391) | 2.10305024 |
71 | Myokymia (HP:0002411) | 2.09254429 |
72 | Areflexia of lower limbs (HP:0002522) | 2.04687090 |
73 | Focal seizures (HP:0007359) | 2.02711779 |
74 | Muscular dystrophy (HP:0003560) | 1.99009094 |
75 | Testicular atrophy (HP:0000029) | 1.94624843 |
76 | Hip contracture (HP:0003273) | 1.94053274 |
77 | Central scotoma (HP:0000603) | 1.93590607 |
78 | Abnormality of the foot musculature (HP:0001436) | 1.93352896 |
79 | Ragged-red muscle fibers (HP:0003200) | 1.92700115 |
80 | Ulnar deviation of the wrist (HP:0003049) | 1.88896011 |
81 | Visual hallucinations (HP:0002367) | 1.88532493 |
82 | Foot dorsiflexor weakness (HP:0009027) | 1.86818606 |
83 | Broad-based gait (HP:0002136) | 1.85652223 |
84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84496849 |
85 | Bulbar palsy (HP:0001283) | 1.84165356 |
86 | Papilledema (HP:0001085) | 1.79344034 |
87 | Limb-girdle muscle weakness (HP:0003325) | 1.77800108 |
88 | Spinal rigidity (HP:0003306) | 1.76018020 |
89 | Pheochromocytoma (HP:0002666) | 1.74449966 |
90 | Toxemia of pregnancy (HP:0100603) | 1.74216081 |
91 | Aortic aneurysm (HP:0004942) | 1.74048727 |
92 | Generalized muscle weakness (HP:0003324) | 1.71540715 |
93 | Hyperkalemia (HP:0002153) | 1.70439088 |
94 | Sudden cardiac death (HP:0001645) | 1.69665528 |
95 | Rapidly progressive (HP:0003678) | 1.69283997 |
96 | Poor eye contact (HP:0000817) | 1.68279870 |
97 | Bicuspid aortic valve (HP:0001647) | 1.66841524 |
98 | Bradycardia (HP:0001662) | 1.66047559 |
99 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65671024 |
100 | Impaired social interactions (HP:0000735) | 1.63720548 |
101 | Abnormal social behavior (HP:0012433) | 1.63720548 |
102 | Absent phalangeal crease (HP:0006109) | 1.63688551 |
103 | Febrile seizures (HP:0002373) | 1.63384458 |
104 | Palmoplantar keratoderma (HP:0000982) | 1.62978410 |
105 | Cerebral aneurysm (HP:0004944) | 1.61060777 |
106 | Hamartoma of the eye (HP:0010568) | 1.60419317 |
107 | Congestive heart failure (HP:0001635) | 1.59361898 |
108 | Waddling gait (HP:0002515) | 1.58087270 |
109 | Ankle clonus (HP:0011448) | 1.56648732 |
110 | Childhood onset (HP:0011463) | 1.56449469 |
111 | Limited hip movement (HP:0008800) | 1.55244590 |
112 | Skin pits (HP:0100276) | 1.47651360 |
113 | Pulmonary artery stenosis (HP:0004415) | 1.46891954 |
114 | Abnormality of the tricuspid valve (HP:0001702) | 1.43343339 |
115 | Periauricular skin pits (HP:0100277) | 1.43278291 |
116 | Preauricular pit (HP:0004467) | 1.43278291 |
117 | Hypoplastic left heart (HP:0004383) | 1.42198179 |
118 | Skin nodule (HP:0200036) | 1.39879611 |
119 | Abnormality of the endocardium (HP:0004306) | 1.37278074 |
120 | Calcaneovalgus deformity (HP:0001848) | 1.36866258 |
121 | Hypoplastic heart (HP:0001961) | 1.36447851 |
122 | Resting tremor (HP:0002322) | 1.36286455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 4.79357917 |
2 | OBSCN | 4.52685553 |
3 | PHKG2 | 3.68957291 |
4 | PHKG1 | 3.68957291 |
5 | MYLK | 3.03955791 |
6 | LMTK2 | 2.80528949 |
7 | TRIB3 | 2.06620838 |
8 | PDK3 | 2.02444462 |
9 | PDK4 | 2.02444462 |
10 | NTRK3 | 1.88208898 |
11 | RIPK1 | 1.86347789 |
12 | EPHA4 | 1.85317747 |
13 | MARK1 | 1.75719219 |
14 | AKT3 | 1.66154443 |
15 | PIK3CA | 1.65501254 |
16 | PINK1 | 1.62319211 |
17 | PRKD3 | 1.50426565 |
18 | MAP3K9 | 1.49704617 |
19 | MAP3K4 | 1.41239095 |
20 | NEK9 | 1.40681371 |
21 | MAP3K7 | 1.40555118 |
22 | PKN2 | 1.37603643 |
23 | EPHA3 | 1.36072129 |
24 | PAK6 | 1.32158749 |
25 | MUSK | 1.30543523 |
26 | CDC42BPA | 1.29923649 |
27 | STK38L | 1.29252463 |
28 | STK38 | 1.27455919 |
29 | DAPK2 | 1.26760402 |
30 | PDK2 | 1.23556916 |
31 | EEF2K | 1.22159968 |
32 | MAPKAPK3 | 1.20697092 |
33 | PDGFRA | 1.20045571 |
34 | PAK3 | 1.18940816 |
35 | NEK1 | 1.17867176 |
36 | NTRK2 | 1.10442337 |
37 | MAP3K6 | 1.05047904 |
38 | FRK | 1.04692183 |
39 | PIK3CG | 1.04419592 |
40 | MAP2K4 | 1.02031262 |
41 | CAMK1G | 1.01134017 |
42 | TIE1 | 1.01049525 |
43 | INSRR | 1.00790415 |
44 | * DMPK | 0.98739859 |
45 | MINK1 | 0.98339664 |
46 | KSR2 | 0.97685224 |
47 | CAMK2D | 0.96770767 |
48 | MAPK12 | 0.96742546 |
49 | NLK | 0.96272035 |
50 | CAMK1 | 0.95787025 |
51 | CAMKK1 | 0.92343294 |
52 | PRKD1 | 0.91739934 |
53 | MAPK7 | 0.90270837 |
54 | TAOK1 | 0.87720352 |
55 | STK24 | 0.87549300 |
56 | SGK3 | 0.87438992 |
57 | PRKCH | 0.86511199 |
58 | CAMK2A | 0.80089775 |
59 | PTK2B | 0.79973610 |
60 | PRKAA1 | 0.79915962 |
61 | CAMK4 | 0.77317139 |
62 | LATS2 | 0.75665479 |
63 | WNK1 | 0.75222008 |
64 | EPHB1 | 0.74458691 |
65 | MAPK4 | 0.74195727 |
66 | RET | 0.73323848 |
67 | KSR1 | 0.72574003 |
68 | SGK2 | 0.72449576 |
69 | CDK5 | 0.71716445 |
70 | * ROCK1 | 0.71188854 |
71 | CAMK1D | 0.68584419 |
72 | ICK | 0.68371252 |
73 | MARK2 | 0.67577234 |
74 | NTRK1 | 0.67285883 |
75 | MAP2K7 | 0.66982515 |
76 | PKN1 | 0.65624882 |
77 | SGK1 | 0.64896304 |
78 | DDR2 | 0.63684553 |
79 | UHMK1 | 0.60532505 |
80 | NME1 | 0.60432232 |
81 | GRK7 | 0.59860281 |
82 | PRKAA2 | 0.59685410 |
83 | PDPK1 | 0.59452598 |
84 | ZAK | 0.59061124 |
85 | CAMK2G | 0.58873974 |
86 | TGFBR2 | 0.58744366 |
87 | PAK2 | 0.58110944 |
88 | TYRO3 | 0.57773892 |
89 | CAMK2B | 0.57713125 |
90 | ILK | 0.57598142 |
91 | MAP2K3 | 0.57587730 |
92 | STK11 | 0.57350945 |
93 | DAPK3 | 0.57241720 |
94 | SIK2 | 0.56658149 |
95 | SGK223 | 0.56019455 |
96 | SGK494 | 0.56019455 |
97 | RPS6KL1 | 0.55943503 |
98 | RPS6KC1 | 0.55943503 |
99 | PDK1 | 0.55857363 |
100 | PRPF4B | 0.55386792 |
101 | FER | 0.55051888 |
102 | MAPK13 | 0.54660438 |
103 | MAP2K1 | 0.53713428 |
104 | RPS6KA2 | 0.52887732 |
105 | MTOR | 0.52855827 |
106 | FGFR3 | 0.52684387 |
107 | PRKCE | 0.52171586 |
108 | RPS6KA6 | 0.51558636 |
109 | MAP3K5 | 0.51207901 |
110 | LIMK1 | 0.50494824 |
111 | PDGFRB | 0.47953885 |
112 | ROCK2 | 0.47670450 |
113 | PRKACG | 0.46134328 |
114 | PRKACB | 0.45982730 |
115 | EPHB2 | 0.45843691 |
116 | RPS6KA3 | 0.44280610 |
117 | MAPK10 | 0.41557010 |
118 | PLK2 | 0.40758976 |
119 | CAMKK2 | 0.40228441 |
120 | PRKG1 | 0.38964436 |
121 | LATS1 | 0.38852382 |
122 | GRK5 | 0.37206615 |
123 | FGFR2 | 0.36957499 |
124 | TRPM7 | 0.36686053 |
125 | PRKACA | 0.35344584 |
126 | SIK1 | 0.34464296 |
127 | RPS6KA1 | 0.29369711 |
128 | JAK2 | 0.29125040 |
129 | JAK1 | 0.27387057 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.10760184 |
2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.88802176 |
3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.76624533 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.68374250 |
5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.32160556 |
6 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.21250578 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97635721 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 1.83647643 |
9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77653996 |
10 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68062939 |
11 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66585560 |
12 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64788591 |
13 | Insulin secretion_Homo sapiens_hsa04911 | 1.63909451 |
14 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.60595121 |
15 | Renin secretion_Homo sapiens_hsa04924 | 1.57382563 |
16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56703841 |
17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54829233 |
18 | Morphine addiction_Homo sapiens_hsa05032 | 1.54207448 |
19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51717822 |
20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.50269256 |
21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48735285 |
22 | Salivary secretion_Homo sapiens_hsa04970 | 1.46539001 |
23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45318897 |
24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.42127948 |
25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.40048041 |
26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.38010632 |
27 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.32241379 |
28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.30235371 |
29 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.24339192 |
30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22866945 |
31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22697001 |
32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.21778488 |
33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21021973 |
34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.15014072 |
35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.14181169 |
36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13277296 |
37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10615940 |
38 | Taste transduction_Homo sapiens_hsa04742 | 1.08576678 |
39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07770773 |
40 | Gap junction_Homo sapiens_hsa04540 | 0.98105334 |
41 | Insulin resistance_Homo sapiens_hsa04931 | 0.96658660 |
42 | * Focal adhesion_Homo sapiens_hsa04510 | 0.96174968 |
43 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.95851941 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95143674 |
45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94964673 |
46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92241714 |
47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91514235 |
48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90171093 |
49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89706998 |
50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89428862 |
51 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87629916 |
52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86780366 |
53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86100158 |
54 | Long-term depression_Homo sapiens_hsa04730 | 0.84176845 |
55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83707921 |
56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81453712 |
57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80862312 |
58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80226454 |
59 | Glioma_Homo sapiens_hsa05214 | 0.78790666 |
60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76975746 |
61 | Axon guidance_Homo sapiens_hsa04360 | 0.76129282 |
62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76111368 |
63 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75613523 |
64 | Tight junction_Homo sapiens_hsa04530 | 0.75298443 |
65 | Melanogenesis_Homo sapiens_hsa04916 | 0.73804034 |
66 | Bile secretion_Homo sapiens_hsa04976 | 0.72292730 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70090516 |
68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69623675 |
69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68440575 |
70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68370810 |
71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67428452 |
72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67063168 |
73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66418328 |
74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66417095 |
75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65258400 |
76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64608703 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63818361 |
78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62111946 |
79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60656489 |
80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59775296 |
81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59727934 |
82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59715340 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59638462 |
84 | Amoebiasis_Homo sapiens_hsa05146 | 0.58727944 |
85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56814579 |
86 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53063767 |
87 | Platelet activation_Homo sapiens_hsa04611 | 0.52532366 |
88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52428887 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51836592 |
90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51588166 |
91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50898636 |
92 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50757181 |
93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50570298 |
94 | ABC transporters_Homo sapiens_hsa02010 | 0.50528149 |
95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50255625 |
96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49334338 |
97 | Adherens junction_Homo sapiens_hsa04520 | 0.48857374 |
98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48309217 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47936337 |
100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47125889 |
101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44975701 |
102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44344420 |
103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43965112 |
104 | Lysine degradation_Homo sapiens_hsa00310 | 0.43428370 |
105 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42905014 |
106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41836947 |
107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40961465 |
108 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40204673 |
109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39934154 |
110 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39243810 |
111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38942160 |
112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37468169 |
113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36287798 |
114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35761611 |
115 | Mineral absorption_Homo sapiens_hsa04978 | 0.34582583 |
116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33950821 |